Belgium · Biotechnology startup
Belgium · Complix
Complix is a biopharmaceutical company developing Alphabodies, a novel class of biopharmaceuticals.
Funding reportedLast round: Grant
What company datasets say Complix raised
Funding, as reported
Reported in all26.6Min the source's currency
Rounds5
Last roundGrant
Last round dateSept 2020
Investors listed11
Founders and team
From Complix's own website: 3 on the team.
- Dr. Mark VaeckChief Executive Officer
- Dr. Ignace LastersChief Technology Officer
- Ian PatersonChief Strategy Officer
Biotechnology in Belgium
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Complix in front of investors. Or tell us what we have wrong.